CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023
Cash Flows From Operating Activities:
Net income	$ 10,153	$ 19,750
Adjustments to reconcile net income to net cash provided by operating activities
Depreciation and amortization	19,248	18,956
Deferred income taxes	(45)	122
Stock-based compensation expense	3,382	4,165
Debt issue cost amortization recorded in interest expense	379	225
Other	3,248	987
Changes in operating assets and liabilities, net of acquisitions:
Trade receivables	6,012	(14,358)
Inventories	5,500	(1,344)
Prepaid expenses and other assets	142	(1,553)
Accounts payable	(12,259)	2,871
Accrued liabilities	(6,302)	(2,689)
Net cash provided by operating activities	29,458	27,132
Cash Flows From Investing Activities:
Consideration paid for acquisitions, net of cash acquired	(25,231)	(11,004)
Purchase of property and equipment	(6,903)	(7,850)
Net cash used in investing activities	(32,134)	(18,854)
Cash Flows From Financing Activities:
Proceeds from issuance of long-term debt	76,898	11,000
Principal payments of long-term debt and finance lease obligations	(61,333)	(22,325)
Payment of contingent consideration	(2,450)
Payment of debt issuance costs	(2,329)
Dividends paid to stockholders	(1,505)	(1,348)
Tax withholdings related to net share settlements of restricted stock	(1,596)	(1,827)
Net cash provided by (used in) financing activities	7,685	(14,500)
Effect of foreign exchange rate changes on cash	208	(556)
Net increase (decrease) in cash and cash equivalents	5,217	(6,778)
Cash and cash equivalents at beginning of period	31,901	30,614
Cash and cash equivalents at end of period	37,118	23,836
Supplemental disclosure of cash flow information:
Stock issued for acquisitions	6,250	7,329
Stock issued to settle contingent consideration	4,874
Property, plant and equipment purchases in accounts payable or accrued expenses	952	1,960
Debt issuance costs in accounts payable or accrued expenses	$ 568	$ 185